ENZREL INC has a total of 22 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are TAP PHARMACEUTICAL PROD INC, WEX MEDICAL INSTRUMENTATION CO and N GENE RES LABORATORIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Sugars | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Yatvin Milton B | 20 |
#2 | Pederson Richard L | 6 |
#3 | Betageri Guru | 5 |
#4 | Pederson Richard | 4 |
#5 | Betageri Guru V | 1 |
#6 | Yatvin Milton | 1 |
#7 | Meredith Michael J | 1 |
Publication | Filing date | Title |
---|---|---|
AU2006246495A1 | Liposome drug delivery | |
WO2006062506A1 | Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds | |
AU2003210477A8 | Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds | |
US7045543B2 | Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites | |
US6664257B2 | Anti-mycobacterial compounds | |
US6455073B1 | Covalent microparticle-drug conjugates for biological targeting | |
US6689760B1 | Anti-mycobacterial compositions | |
US6761901B1 | Liposome drug delivery |